SCHEMBL6971216

SCHEMBL6971216

COc1ccc(C(=O)N2CCC(O)c3cc(Cl)ccc32)cc1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPTLC2 O15270 4/20 0.63
PDE4A P27815 1/20 0.49
PDE4B Q07343 1/20 0.49
PDE4C Q08493 1/20 0.49
PDE4D Q08499 1/20 0.49
KDM4E B2RXH2 1/20 0.47
TP53 P04637 1/20 0.47
ALDH1A1 P00352 3/20 0.46
BCHE P06276 2/20 0.46
ACHE P22303 2/20 0.46
SPTLC3 Q9NUV7 1/20 0.46
LMNA P02545 3/20 0.45
AVPR2 P30518 2/20 0.44
AVPR1A P37288 2/20 0.44
ABCB11 O95342 1/20 0.44
ADRB2 P07550 1/20 0.44
HTR1A P08908 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
TBXA2R P21731 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6973987 0.91 SPTLC2 (0.71) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL6418776 0.85 PDE4A (0.61) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL6981749 0.83 SPTLC2 (0.85) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL6970294 0.82 SPTLC2 (0.66) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL6983112 0.82 SPTLC2 (0.76) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL6975238 0.77 SPTLC2 (1.00) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL6968663 0.77 SPTLC2 (0.84) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL6978525 0.76 SPTLC2 (0.56) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL6982993 0.76 SPTLC2 (0.77) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL6981735 0.76 SPTLC2 (0.89) SPTLC2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216398-A1 Soluble beta amyloid precursor protein secretion promoters TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-11-20 US disclosed
EP-1283055-A1 SOLUBLE BETA AMYLOID PRECURSOR PROTEIN SECRETION PROMOTERS Takeda Chemical Industries, Ltd. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216398-A1 Soluble beta amyloid precursor protein secretion promoters APP, BDNF, BACE1 SPTLC2 3161/4885PDE4A 2235/4885PDE4B 2563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.